Programme

SATURDAY, MARCH 17, 2018

18:00                          Networking session followed by a Networking Dinner

SUNDAY, MARCH 18, 2018

09:00                          The basics of tumor immunology (Leif Hakansson)

09:30                          Cancer genetics and checkpoint inhibition (Marco Gerlinger)

10:00                          What we learned from immunotherapy in the past years (Paolo Ascierto)

10:30                         Cell Therapy (John Haanen)

11:00                          COFFEE BREAK

11:30                          Breakout sessions (1)

– 11:30 Melanoma and Merkel Cell Carcinoma (Group A) (Caroline Robert)

– 11:30 Lung (Group B) (Rudolf Maria Huber)

– 12:00 Melanoma and Merkel Cell Carcinoma (Group B) (Caroline Robert)

– 12:00 Lung (Group A) (Rudolf Maria Huber)

12:30                          LUNCH

13:30                          Breakout sessions (2)

– 13:30 – 14:15 GU-Tumors (Group A) (TBA)

– 13:30 – 14:15 Haematological malignancies (Group B) (Michael von Bergwelt)

– 14:15 – 15:00 GU-Tumors (Group B) (TBA)

– 14:15 – 15:00 Haematological malignancies (Group A) (Michael von Bergwelt)

15:00                          Management of toxicity (Christoph Zielinski)

15:30                          Biomarkers (Heinz Zwierzina)

16:00                         COFFEE BREAK

16:30                          Rationale for combination therapy (Paolo Ascierto)

17:00                          The role of vaccine in the era of checkpoint inhibitors (Cornelis Melief)

17:30                          Round table discussion

18:00                          END OF THE COURSE